-
Galloway accuser could not foresee publishing-sector fallout, lawyer argues
-
No. 22 UCLA defeats No. 5 Arizona 84-75 despite Kharchenkov's 38 points
-
New York City Center revives In the Heights as a timely community story
-
Vessel operator seeks witnesses after Vancouver grounding
-
Godzilla Minus Zero shifts focus toward postwar human drama
-
US Air Force deploys F-16 fighters to remote Aleutian base for readiness drill
-
Mehbooba Mufti urges dialogue and renewed Central Asia links for Kashmir
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Seacliff Healthcare Seeks Specialist GP in Thirroul
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
India proposes more import entry points for drugs and medical devices
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
2026 Arizona Midterms: Key Races, Ballot Measures, and Voter Deadlines
-
NBC’s Steve Kornacki Reveals Tech Habits Ahead of Midterm Elections
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
India and Israel oppose UN draft on regional conventional arms control
-
Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination
-
BLS Polymers shares open 65.3% above IPO price
-
US Buildings Threatened by Wildfires Could Triple by 2060
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise
-
Latino Voters Defy ICE Fears, Turn Out in Record Numbers for Midterms
-
US Strikes Iranian Targets in Strait of Hormuz Ahead of Midterms
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Brodeur’s Overtime Goal Secures Bethlehem’s Second Consecutive Sectional Title
-
Reliance rally puts historical one-year return pattern in focus
-
Rare 1970 Plymouth ‘Cuda 426 Hemi Listed for $400,000
-
Kuwait edges Oman 1-0 in veterans Gulf Cup in Doha
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
-
Alberta Tabled Controversial Riding Boundary Maps Amid Gerrymandering Accusations
-
Washington reports movement in Iran negotiations aimed at preventing escalation
-
Hong Kong court set to sentence activist Joshua Wong in security case
-
Korea’s Labor Share of GDP Hits Record Low Amid Semiconductor Boom
-
Australia raises benchmark rate to highest level in 18 years
-
littlefish and Halo Dot Partner to Replace Payment Terminals with SoftPOS
-
'The Remarried Empress' Cast Discusses Bringing Fantasy Royal Drama to Life
-
Kuwait inspectors destroy 115 kilograms of unverified meat in Farwaniya
-
Asian stocks retreat as AI worries outweigh steep oil-price drop
-
Egypt Accelerates Construction of 341km Sinai Railway Linking Arish and Taba
-
Hamad International Airport stages emergency drills during WATAN 2026
-
John Schneider Admits Owes Millions in 'Dukes of Hazzard' Divorce Battle
-
Global failure to punish attacks leaves journalists at continuing risk
-
Philippine Authorities Report Progress in Thomas Markle Sr. Child Pornography Probe
Trump aides blocked accurate Covid information: US probe
Former US president Donald Trump's administration prevented health officials from providing accurate information about Covid-19 in a bid to back up his overly optimistic view of the outbreak, according to a congressional report released Monday.
Senior staff at the US Centers for Disease Control and Prevention (CDC) told investigators Trump aides bullied staff and tried to rewrite their reports in a bid to align guidance with the president's public downplaying of the crisis.
Officials took "unprecedented steps to insert political appointees into the publication process and rebut CDC's scientific reports, including drafting op-eds and other public messaging designed to directly counteract CDC's findings," the report said.
Investigators interviewed a dozen current and former CDC officials as well as senior administration figures for the 91-page document released by the House select subcommittee on the coronavirus crisis.
The panel describes how Trump appointees at the Department of Health and Human Services (HHS) tried to take over the CDC's weekly scientific journal, the Morbidity and Mortality Weekly Report (MMWR), editing or blocking articles they believed might prove harmful to Trump.
Trump appointees had sought to "alter the contents, rebut, or delay the release" of 18 MMWRs and a health alert, succeeding on at least five occasions.
The report quoted a CDC communications officer who complained that a Trump ally in HHS had used "bully-ish behavior" that made CDC officials "feel threatened."
Jay Butler, the CDC's deputy director of infectious diseases, said he was "not really asked back to do telebriefings" after his statements were deemed "too alarming."
"The Select Subcommittee's investigation has shown that the previous administration engaged in an unprecedented campaign of political interference in the federal government's pandemic response, which undermined public health to benefit the former president's political goals," panel chairman Jim Clyburn, a Democrat, said in a statement.
"As today's report shows, President Trump and his top aides repeatedly attacked CDC scientists, compromised the agency's public health guidance, and suppressed scientific reports in an effort to downplay the seriousness of the coronavirus."
A previous report outlined the Trump administration's bid to block government health officials from speaking publicly about the pandemic.
And another described its pressure on the US Food and Drug Administration to reissue emergency authorization for hydroxychloroquine, an anti-malaria drug Trump was promoting despite its ineffectiveness in treating Covid-19.
Republicans dismissed the latest report as partisan and have vowed to conduct their own inquiry if they win back the House or the Senate in November's midterm elections.
C.Kovalenko--BTB